Published in Eur Neuropsychopharmacol on March 01, 2007
Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects. Schizophr Bull (2009) 1.45
Reduced capacity but spared precision and maintenance of working memory representations in schizophrenia. Arch Gen Psychiatry (2010) 1.37
The myth of schizophrenia as a progressive brain disease. Schizophr Bull (2012) 1.21
The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue. Front Psychiatry (2014) 1.14
The neuropsychiatry of inborn errors of metabolism. J Inherit Metab Dis (2013) 1.07
Prenatal exposure to infection: a primary mechanism for abnormal dopaminergic development in schizophrenia. Psychopharmacology (Berl) (2009) 1.01
Schizophrenia: do all roads lead to dopamine or is this where they start? Evidence from two epidemiologically informed developmental rodent models. Transl Psychiatry (2012) 1.00
Life events and high-trait reactivity together predict psychotic symptom increases in schizophrenia. Schizophr Bull (2008) 0.97
Developmental origins of brain disorders: roles for dopamine. Front Cell Neurosci (2013) 0.94
Drug-induced psychosis: how to avoid star gazing in schizophrenia research by looking at more obvious sources of light. Front Behav Neurosci (2011) 0.94
The epidemiology of schizophrenia: replacing dogma with knowledge. Dialogues Clin Neurosci (2010) 0.92
BDNF and schizophrenia: from neurodevelopment to neuronal plasticity, learning, and memory. Front Psychiatry (2013) 0.91
Polysialic acid is required for dopamine D2 receptor-mediated plasticity involving inhibitory circuits of the rat medial prefrontal cortex. PLoS One (2011) 0.86
GABA(B) receptors, schizophrenia and sleep dysfunction: a review of the relationship and its potential clinical and therapeutic implications. CNS Drugs (2009) 0.83
Paliperidone: the evidence of its therapeutic value in schizophrenia. Core Evid (2008) 0.83
New atypical antipsychotics for schizophrenia: iloperidone. Drug Des Devel Ther (2010) 0.83
Altered dopamine ontogeny in the developmentally vitamin D deficient rat and its relevance to schizophrenia. Front Cell Neurosci (2013) 0.82
Cannabidiol Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization of the Mesolimbic Dopamine Pathway through a Novel mTOR/p70S6 Kinase Signaling Pathway. J Neurosci (2016) 0.81
Associations between DRDs and schizophrenia in a Korean population: multi-stage association analyses. Exp Mol Med (2011) 0.81
Cholecystokinin A receptor (CCKAR) gene variation is associated with language lateralization. PLoS One (2013) 0.79
Dopaminergic basis of the psychosis-prone personality investigated with functional magnetic resonance imaging of procedural learning. Front Hum Neurosci (2013) 0.79
Epigenetics, stress, and their potential impact on brain network function: a focus on the schizophrenia diatheses. Front Psychiatry (2014) 0.78
Anxiety interacts with expressed emotion criticism in the prediction of psychotic symptom exacerbation. Schizophr Bull (2009) 0.76
Review of the 6th symposium for the search for the causes of schizophrenia, Sao Paulo, Brazil, 3-6 February 2009. Eur Arch Psychiatry Clin Neurosci (2009) 0.76
Integrated Post-GWAS Analysis Sheds New Light on the Disease Mechanisms of Schizophrenia. Genetics (2016) 0.75
Bridging the gap between research into biological and psychosocial models of psychosis. Shanghai Arch Psychiatry (2015) 0.75
The Impact of Maternal Vitamin D Status on Offspring Brain Development and Function: a Systematic Review. Adv Nutr (2016) 0.75
Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Arch Gen Psychiatry (2006) 9.44
Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet (2013) 7.44
Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry (2004) 5.95
Epigenome-wide scans identify differentially methylated regions for age and age-related phenotypes in a healthy ageing population. PLoS Genet (2012) 4.05
Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiatry (2002) 4.03
A twin study of genetic relationships between psychotic symptoms. Am J Psychiatry (2002) 3.95
Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry (2009) 3.67
Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Arch Gen Psychiatry (2002) 3.59
Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study. Arch Gen Psychiatry (2006) 3.35
Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study. Am J Psychiatry (2010) 3.05
Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Hum Mol Genet (2011) 2.99
Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP Study. Psychol Med (2006) 2.79
Symmetries in human brain language pathways correlate with verbal recall. Proc Natl Acad Sci U S A (2007) 2.78
Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Schizophr Bull (2006) 2.71
Prevalence and correlates of self-reported psychotic symptoms in the British population. Br J Psychiatry (2004) 2.44
High-potency cannabis and the risk of psychosis. Br J Psychiatry (2009) 2.41
Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study. Am J Psychiatry (2011) 2.37
Incidence of schizophrenia and other psychoses in England, 1950-2009: a systematic review and meta-analyses. PLoS One (2012) 2.33
Meta-analysis of the P300 and P50 waveforms in schizophrenia. Schizophr Res (2004) 2.30
Adolescents who were born very preterm have decreased brain volumes. Brain (2002) 1.97
Temporal course of auditory hallucinations. Br J Psychiatry (2004) 1.95
Reliability and comparability of psychosis patients' retrospective reports of childhood abuse. Schizophr Bull (2009) 1.94
Grey and white matter distribution in very preterm adolescents mediates neurodevelopmental outcome. Brain (2007) 1.91
Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes. Arch Gen Psychiatry (2004) 1.87
Regional volume deviations of brain structure in schizophrenia and psychotic bipolar disorder: computational morphometry study. Br J Psychiatry (2005) 1.83
Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study. Neuropsychopharmacology (2005) 1.76
Self-harm in first-episode psychosis. Br J Psychiatry (2008) 1.72
A diffusion tensor imaging study of fasciculi in schizophrenia. Am J Psychiatry (2007) 1.71
Neural responses to sad facial expressions in major depression following cognitive behavioral therapy. Biol Psychiatry (2008) 1.70
Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users. Biol Psychiatry (2012) 1.64
Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology (2009) 1.62
Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient data. Biol Psychiatry (2010) 1.60
Neurocognitive deficits in first-episode schizophrenic patients and their first-degree relatives. Am J Med Genet B Neuropsychiatr Genet (2007) 1.59
Pathways to schizophrenia: the impact of environmental factors. Int J Neuropsychopharmacol (2004) 1.58
Migration, ethnicity, and psychosis: toward a sociodevelopmental model. Schizophr Bull (2010) 1.58
Corpus callosum size and very preterm birth: relationship to neuropsychological outcome. Brain (2004) 1.55
Clinical and social determinants of duration of untreated psychosis in the AESOP first-episode psychosis study. Br J Psychiatry (2006) 1.53
Searching for psychosis: INTREPID (1): systems for detecting untreated and first-episode cases of psychosis in diverse settings. Soc Psychiatry Psychiatr Epidemiol (2015) 1.50
Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: the role of stress and of antipsychotic treatment. Schizophr Res (2009) 1.48
Substantial shared genetic influences on schizophrenia and event-related potentials. Am J Psychiatry (2007) 1.48
Meta-analysis of magnetic resonance imaging brain morphometry studies in bipolar disorder. Biol Psychiatry (2004) 1.45
Community screening for psychotic-like experiences and other putative antecedents of schizophrenia in children aged 9-12 years. Schizophr Res (2007) 1.44
Gender differences in incidence and age at onset of mania and bipolar disorder over a 35-year period in Camberwell, England. Am J Psychiatry (2005) 1.42
Cannabis use and outcome of recent onset psychosis. Eur Psychiatry (2005) 1.42
A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample. Proc Natl Acad Sci U S A (2006) 1.40
Neighbourhood-level effects on psychoses: re-examining the role of context. Psychol Med (2007) 1.38
Preterm birth and psychiatric disorders in young adult life. Arch Gen Psychiatry (2012) 1.38
Schizophrenia. BMJ (2007) 1.37
Association between BDNF val66 met genotype and episodic memory. Am J Med Genet B Neuropsychiatr Genet (2005) 1.36
Regional brain morphometry in patients with schizophrenia or bipolar disorder and their unaffected relatives. Am J Psychiatry (2006) 1.35
The structural brain correlates of neurological soft signs in AESOP first-episode psychoses study. Brain (2003) 1.35
Pattern of neural responses to verbal fluency shows diagnostic specificity for schizophrenia and bipolar disorder. BMC Psychiatry (2011) 1.34
Gene-environment interplay between cannabis and psychosis. Schizophr Bull (2008) 1.34
Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study. Neuropsychopharmacology (2005) 1.32
Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis. Br J Psychiatry Suppl (2007) 1.31
Cannabis use in young people: the risk for schizophrenia. Neurosci Biobehav Rev (2011) 1.31
Gender differences in the association between childhood abuse and psychosis. Br J Psychiatry (2009) 1.30
The dopaminergic basis of human behaviors: A review of molecular imaging studies. Neurosci Biobehav Rev (2009) 1.30
Dopamine synthesis capacity in patients with treatment-resistant schizophrenia. Am J Psychiatry (2012) 1.29
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment. J Psychopharmacol (2012) 1.29
Meta-analysis of the association of urbanicity with schizophrenia. Schizophr Bull (2012) 1.29
Does dopamine mediate the psychosis-inducing effects of cannabis? A review and integration of findings across disciplines. Schizophr Res (2010) 1.26
Prevalence of violent victimisation in severe mental illness. Br J Psychiatry (2003) 1.25
What causes the onset of psychosis? Schizophr Res (2005) 1.24
Excellent school performance at age 16 and risk of adult bipolar disorder: national cohort study. Br J Psychiatry (2010) 1.24
White matter and cognition in adults who were born preterm. PLoS One (2011) 1.23
Is the P300 wave an endophenotype for schizophrenia? A meta-analysis and a family study. Neuroimage (2005) 1.23
The very preterm brain in young adulthood: the neural correlates of verbal paired associate learning. J Pediatr (2010) 1.22
Heritability and reliability of P300, P50 and duration mismatch negativity. Behav Genet (2006) 1.22
The myth of schizophrenia as a progressive brain disease. Schizophr Bull (2012) 1.21
Specific and generalized neuropsychological deficits: a comparison of patients with various first-episode psychosis presentations. Am J Psychiatry (2009) 1.20
Full spectrum of psychiatric outcomes among offspring with parental history of mental disorder. Arch Gen Psychiatry (2010) 1.19
Cerebellar growth and behavioural & neuropsychological outcome in preterm adolescents. Brain (2008) 1.18
White matter integrity as a predictor of response to treatment in first episode psychosis. Brain (2013) 1.16
Impaired intellect and memory: a missing link between genetic risk and schizophrenia? Arch Gen Psychiatry (2010) 1.15
Epistasis between the DAT 3' UTR VNTR and the COMT Val158Met SNP on cortical function in healthy subjects and patients with schizophrenia. Proc Natl Acad Sci U S A (2009) 1.15
Neurological soft signs in first-episode psychosis: a systematic review. Br J Psychiatry Suppl (2002) 1.15
Higher cortisol levels are associated with smaller left hippocampal volume in first-episode psychosis. Schizophr Res (2010) 1.13
The early auditory gamma-band response is heritable and a putative endophenotype of schizophrenia. Schizophr Bull (2009) 1.13
Suicide and other causes of mortality in bipolar disorder: a longitudinal study. Psychol Med (2007) 1.12
A functional MRI study of working memory task in euthymic bipolar disorder: evidence for task-specific dysfunction. Bipolar Disord (2004) 1.12
P50 auditory evoked potential suppression in bipolar disorder patients with psychotic features and their unaffected relatives. Biol Psychiatry (2006) 1.12
Prevalence of psychotic symptoms in substance users: a comparison across substances. Compr Psychiatry (2008) 1.11
Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations. Schizophr Bull (2014) 1.10
Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis. Am J Med Genet B Neuropsychiatr Genet (2005) 1.10
Duration of untreated psychosis and ethnicity in the AESOP first-onset psychosis study. Psychol Med (2005) 1.09
Cortical folding defects as markers of poor treatment response in first-episode psychosis. JAMA Psychiatry (2013) 1.08
Engagement of brain areas implicated in processing inner speech in people with auditory hallucinations. Br J Psychiatry (2003) 1.08
Gray matter abnormalities associated with duration of untreated psychosis. Schizophr Res (2006) 1.07
How genes and environmental factors determine the different neurodevelopmental trajectories of schizophrenia and bipolar disorder. Schizophr Bull (2011) 1.07
Volumetric abnormalities predating the onset of schizophrenia and affective psychoses: an MRI study in subjects at ultrahigh risk of psychosis. Schizophr Bull (2011) 1.07
Why do patients with psychosis use cannabis and are they ready to change their use? Int J Dev Neurosci (2010) 1.06
Reduced mismatch negativity predates the onset of psychosis. Schizophr Res (2011) 1.05
Cannabis use and psychiatric and cogitive disorders: the chicken or the egg? Curr Opin Psychiatry (2007) 1.04
Biological, life course, and cross-cultural studies all point toward the value of dimensional and developmental ratings in the classification of psychosis. Schizophr Bull (2007) 1.02
Serum and gene expression profile of cytokines in first-episode psychosis. Brain Behav Immun (2012) 1.02
Association between symptom dimensions and categorical diagnoses of psychosis: a cross-sectional and longitudinal investigation. Schizophr Bull (2013) 1.01
Differential methylation of the X-chromosome is a possible source of discordance for bipolar disorder female monozygotic twins. Am J Med Genet B Neuropsychiatr Genet (2008) 1.01
Mismatch negativity in schizophrenia: a family study. Schizophr Res (2004) 1.01
Antisaccade performance in monozygotic twins discordant for schizophrenia: the Maudsley twin study. Am J Psychiatry (2006) 1.01